Employees: 12 (2023.0)Legal category: 5785Size: PMECreation date: 2006-01-27 (20 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: LA CIOTAT (13600), Bouches-du-Rhone
PHARMACIE DU GOLFE : revenue, balance sheet and financial ratios
PHARMACIE DU GOLFE is a French company
founded 20 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in LA CIOTAT (13600),
this company of category PME
shows in 2023 a revenue of 7.4 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DU GOLFE (SIREN 488328832)
Indicator
2025
2024
2023
2022
2021
2019
2017
2016
Revenue
N/C
N/C
7 428 530 €
N/C
N/C
5 208 966 €
4 001 728 €
3 520 961 €
Net income
566 732 €
369 137 €
337 486 €
465 922 €
250 792 €
74 792 €
249 898 €
221 287 €
EBITDA
N/C
N/C
515 873 €
N/C
N/C
97 672 €
272 753 €
269 426 €
Net margin
N/C
N/C
4.5%
N/C
N/C
1.4%
6.2%
6.3%
Revenue and income statement
In 2025, PHARMACIE DU GOLFE generates positive net income of 567 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 221 k€ -> 567 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
566 732 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 87%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 40%. The balance between equity and debt is satisfactory.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
86.972%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
39.775%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2019
2021
2022
2023
2024
2025
Debt ratio
85.975
90.967
506.659
103.81
80.286
96.838
94.185
86.972
Financial autonomy
38.702
38.221
12.566
38.678
43.349
36.613
38.866
39.775
Repayment capacity
2.809
2.619
8.675
None
None
3.392
None
None
Cash flow / Revenue
7.306%
7.376%
4.026%
None%
None%
6.119%
None%
None%
Sector positioning
Debt ratio
86.972025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Average
In 2025, the debt ratio of PHARMACIE DU GOLFE (86.97) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
39.77%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Average
In 2025, the financial autonomy of PHARMACIE DU GOLFE (39.8%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
3.39 years2023
2023
Q1: 0.95 years
Med: 3.58 years
Q3: 7.48 years
Good
In 2023, the repayment capacity of PHARMACIE DU GOLFE (3.39) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 293.15. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
293.15
Liquidity indicators evolution PHARMACIE DU GOLFE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2019
2021
2022
2023
2024
2025
Liquidity ratio
153.343
171.55
190.072
301.503
323.987
257.936
297.502
293.15
Interest coverage
3.897
3.177
13.36
None
None
0.056
None
None
Sector positioning
Liquidity ratio
293.152025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Excellent
In 2025, the liquidity ratio of PHARMACIE DU GOLFE (293.15) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
0.06x2023
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Average
In 2023, the interest coverage of PHARMACIE DU GOLFE (0.1x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DU GOLFE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2019
2021
2022
2023
2024
2025
Operating WCR
523 849 €
600 899 €
821 610 €
0 €
0 €
1 369 227 €
0 €
0 €
Inventory turnover (days)
48
46
52
0
0
41
0
0
Customer payment term (days)
2
3
5
0
0
8
0
0
Supplier payment term (days)
61
54
42
0
0
54
0
0
Positioning of PHARMACIE DU GOLFE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DU GOLFE is estimated at
9 002 605 €
(range 6 109 210€ - 14 126 327€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
6109k€9002k€14126k€
9 002 605 €Range: 6 109 210€ - 14 126 327€
NAF 5 année 2025
Valuation method used
Net Income Multiple
566 732 €
×
15.9x
=9 002 605 €
Range: 6 109 210€ - 14 126 327€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DU GOLFE with other companies in the same sector:
Frequently asked questions about PHARMACIE DU GOLFE
What is the revenue of PHARMACIE DU GOLFE ?
The revenue of PHARMACIE DU GOLFE in 2023 is 7.4 M€.
Is PHARMACIE DU GOLFE profitable?
Yes, PHARMACIE DU GOLFE generated a net profit of 567 k€ in 2025.
Where is the headquarters of PHARMACIE DU GOLFE ?
The headquarters of PHARMACIE DU GOLFE is located in LA CIOTAT (13600), in the department Bouches-du-Rhone.
Where to find the tax return of PHARMACIE DU GOLFE ?
The tax return of PHARMACIE DU GOLFE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DU GOLFE operate?
PHARMACIE DU GOLFE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart